HeartSciences (HSCS) announced that the U.S. Food and Drug Administration has granted Breakthrough Device designationless than BDD, for its Aortic ...

more commonly used valve in our institute, namely, the St Jude Medical Regent aortic mechanical prosthetic valve. This is ‘real life’ data from ‘all comers’ in our institute rather than selected group ...

Conclusions— Severe P-PtM is an independent predictor of higher long-term mortality and congestive heart failure in patients with small St Jude Medical aortic valve prostheses. For patients undergoing ...

St Jude Medical X-Cell, and Carpentier-Edwards Perimount valves. This work was supported by grants from the Canadian Institutes of Health Research (MOP 57745), Ottawa, Canada. Dr Pibarot is the ...

Bileaflet mechanical aortic valves are commonly recommended for aortic valve replacement (AVR) in patients with a longer life expectancy [age ≤50 (1) or 60 years (2)] due to their long-lasting ...

Abbott’s Trifecta devices are intended to treat damaged or malfunctioning aortic heart valves. St. Jude Medical won approval for the first-generation Trifecta device in 2011 and launched its follow-up ...

Based on the published literature, the FDA is concerned that the rate of early deterioration may be higher for Trifecta than for other surgical aortic valve replacement (SAVR ... market through its ...

Transfemoral access remains the most widely used peripheral vascular approach for transcatheter aortic valve implantation (TAVI ... Duct Occluder or Amplatzer Muscular VSD occlude St. Jude Medical, St ...

4D cine imaging of a St. Jude mechanical bileaflet prosthetic heart valve in the aortic position showing a fixed leaflet. Opening and closing angles of two St. Jude mechanical bileaflet prosthetic ...